{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T13:19:10Z","timestamp":1775827150759,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T00:00:00Z","timestamp":1477267200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11892-016-0820-9","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T07:00:36Z","timestamp":1477292436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Metabolomic Biomarkers in the Progression to Type 1 Diabetes"],"prefix":"10.1007","volume":"16","author":[{"given":"Anne Julie","family":"Overgaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simranjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flemming","family":"Pociot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"issue":"12","key":"820_CR1","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1210\/jc.2012-3487","volume":"97","author":"R Sherwin","year":"2012","unstructured":"Sherwin R, Jastreboff AM. Year in diabetes 2012: the diabetes tsunami. J Clin Endocrinol Metab. 2012;97(12):4293\u2013301.","journal-title":"J Clin Endocrinol Metab"},{"key":"820_CR2","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","volume":"387","author":"F Pociot","year":"2016","unstructured":"Pociot F, Lernmark \u00c5. Genetic risk factors for type 1 diabetes. Lancet. 2016;387:2331\u201339.","journal-title":"Lancet"},{"issue":"1","key":"820_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaci.2014.10.015","volume":"135","author":"S Bunyavanich","year":"2015","unstructured":"Bunyavanich S, Schadt EE. Systems biology of asthma and allergic diseases: a multiscale approach. J Allergy Clin Immunol. 2015;135(1):31\u201342.","journal-title":"J Allergy Clin Immunol"},{"issue":"23","key":"820_CR4","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013;309(23):2473\u20139. This study evaluates the 10 year risk of type 1 diabetes after auto antibody seroconversion in a very large cohort.","journal-title":"JAMA"},{"issue":"5","key":"820_CR5","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","volume":"58","author":"JP Krischer","year":"2015","unstructured":"Krischer JP, Lynch KF, Schatz DA, et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia. 2015;58(5):980\u20137. This paper investigates the order and age of appearance of autoantibodies, and relates these to HLA DR DQ genotype.","journal-title":"Diabetologia"},{"issue":"10","key":"820_CR6","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.2337\/db13-0300","volume":"62","author":"J Ilonen","year":"2013","unstructured":"Ilonen J, Hammais A, Laine A-P, et al. Patterns of \u03b2-cell autoantibody appearance and genetic associations during the first years of life. Diabetes. 2013;62(10):3636\u201340. This study links the appearance of the primary autoantibody to the age of onset of type 1 diabetes.","journal-title":"Diabetes"},{"issue":"7","key":"820_CR7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s001250050514","volume":"39","author":"M Rewers","year":"1996","unstructured":"Rewers M, Bugawan TL, Norris JM, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996;39(7):807\u201312.","journal-title":"Diabetologia"},{"issue":"9","key":"820_CR8","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00125-008-1074-0","volume":"51","author":"HE Larsson","year":"2008","unstructured":"Larsson HE, Hansson G, Carlsson A, et al. Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes. Diabetologia. 2008;51(9):1623\u201330.","journal-title":"Diabetologia"},{"issue":"2","key":"820_CR9","first-page":"77","volume":"5","author":"SK Carmichael","year":"2003","unstructured":"Carmichael SK, Johnson SB, Baughcum A, et al. Prospective assessment in newborns of diabetes autoimmunity (PANDA): maternal understanding of infant diabetes risk. Genet Med Off J Am Coll Med Genet. 2003;5(2):77\u201383.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"820_CR10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1196\/annals.1288.067","volume":"1005","author":"E Wion","year":"2003","unstructured":"Wion E, Brantley M, Stevens J, et al. Population-wide infant screening for HLA-based type 1 diabetes risk via dried blood spots from the public health infrastructure. Ann N Y Acad Sci. 2003;1005:400\u20133.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"820_CR11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1099-0895(199806)14:2<188::AID-DMR1210>3.0.CO;2-0","volume":"14","author":"J Ilonen","year":"1998","unstructured":"Ilonen J, Simell O, Knip M, et al. Screening for genetic IDDM risk and prevention trials in infancy. Diabetes Metab Rev. 1998;14(2):188.","journal-title":"Diabetes Metab Rev"},{"issue":"1","key":"820_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00400423","volume":"39","author":"J Ilonen","year":"1996","unstructured":"Ilonen J, Reijonen H, Knip M, et al. Population-based genetic screening for IDDM susceptibility as a source of HLA-genotyped control subjects. Diabetologia. 1996;39(1):123.","journal-title":"Diabetologia"},{"key":"820_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2015.10.013","volume":"589","author":"M-E Dumas","year":"2016","unstructured":"Dumas M-E, Adamski J, Suhre K. Guest editorial: special issue on metabolomics. Arch Biochem Biophys. 2016;589:1\u20133.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"820_CR14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrg3575","volume":"15","author":"M Civelek","year":"2014","unstructured":"Civelek M, Lusis AJ. Systems genetics approaches to understand complex traits. Nat Rev Genet. 2014;15(1):34\u201348.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"820_CR15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2337\/dc15-2251","volume":"39","author":"M Guasch-Ferr\u00e9","year":"2016","unstructured":"Guasch-Ferr\u00e9 M, Hruby A, Toledo E, et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care. 2016;39(5):833\u201346.","journal-title":"Diabetes Care"},{"issue":"6","key":"820_CR16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ng.2982","volume":"46","author":"S-Y Shin","year":"2014","unstructured":"Shin S-Y, Fauman EB, Petersen A-K, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014;46(6):543\u201350.","journal-title":"Nat Genet"},{"key":"820_CR17","doi-asserted-by":"crossref","unstructured":"Rhee EP, Ho JE, Chen M-H. A genome-wide association study of the human metabolome in a community-based cohort. Cell Metabolism. 18(1):130\u201343.","DOI":"10.1016\/j.cmet.2013.06.013"},{"issue":"13","key":"820_CR18","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1084\/jem.20081800","volume":"205","author":"M Oresic","year":"2008","unstructured":"Oresic M, Simell S, Sysi-Aho M, et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med. 2008;205(13):2975\u201384.","journal-title":"J Exp Med"},{"issue":"9","key":"820_CR19","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.2337\/db13-0159","volume":"62","author":"M Oresic","year":"2013","unstructured":"Oresic M, Gopalacharyulu P, Mykkanen J, et al. Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes. Diabetes. 2013;62(9):3268\u201374. This is the first study successfully associating cord blood lipidomics to risk of type 1 diabetes.","journal-title":"Diabetes"},{"issue":"11","key":"820_CR20","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.2337\/db13-0215","volume":"62","author":"D Torre La","year":"2013","unstructured":"La Torre D, Sepp\u00e4nen-Laakso T, Larsson HE, et al. Decreased cord-blood phospholipids in young age-at-onset type 1 diabetes. Diabetes. 2013;62(11):3951\u20136.","journal-title":"Diabetes"},{"issue":"19","key":"820_CR21","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/elps.201300062","volume":"34","author":"C Balderas","year":"2013","unstructured":"Balderas C, Rup\u00e9rez FJ, Iba\u00f1ez E, et al. Plasma and urine metabolic fingerprinting of type 1 diabetic children. Electrophoresis. 2013;34(19):2882\u201390.","journal-title":"Electrophoresis"},{"key":"820_CR22","doi-asserted-by":"crossref","unstructured":"J\u00f8rgenrud B, Stene LC, Tapia G, et al. Longitudinal plasma metabolic profiles, infant feeding, and islet autoimmunity in the MIDIA study. Pediatr Diabetes. 2016;21.","DOI":"10.1111\/pedi.12360"},{"issue":"11","key":"820_CR23","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.2337\/db10-1652","volume":"60","author":"M Pflueger","year":"2011","unstructured":"Pflueger M, Sepp\u00e4nen-Laakso T, Suortti T, et al. Age- and islet autoimmunity\u2013associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes. 2011;60(11):2740\u20137.","journal-title":"Diabetes"},{"issue":"2","key":"820_CR24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2015.01.001","volume":"17","author":"AD Kostic","year":"2015","unstructured":"Kostic AD, Gevers D, Siljander H, et al. The dynamics of the human infant Gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 2015;17(2):260\u201373. This study for the first time identifies a connection between the infant gut microbiome and progression of type 1 diabetes.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"820_CR25","first-page":"1","volume":"12","author":"AJ Overgaard","year":"2015","unstructured":"Overgaard AJ, Weir JM, Souza DPD, et al. Lipidomic and metabolomic characterization of a genetically modified mouse model of the early stages of human type 1 diabetes pathogenesis. Metabolomics. 2015;12(1):1\u20139.","journal-title":"Metabolomics"},{"issue":"11","key":"820_CR26","doi-asserted-by":"crossref","first-page":"E978","DOI":"10.1152\/ajpendo.00019.2015","volume":"308","author":"J Fahrmann","year":"2015","unstructured":"Fahrmann J, Grapov D, Yang J, et al. Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia. Am J Physiol Endocrinol Metab. 2015;308(11):E978\u2013989.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"820_CR27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaut.2009.03.007","volume":"33","author":"A Hewagama","year":"2009","unstructured":"Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun. 2009;33(1):3\u201311.","journal-title":"J Autoimmun"},{"issue":"3","key":"820_CR28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2249.1990.tb05473.x","volume":"82","author":"JC Chuang","year":"1990","unstructured":"Chuang JC, Yu CL, Wang SR. Modulation of lymphocyte proliferation by enzymes that degrade amino acids. Clin Exp Immunol. 1990;82(3):469\u201372.","journal-title":"Clin Exp Immunol"},{"issue":"5932","key":"820_CR29","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1126\/science.1172638","volume":"324","author":"MS Sundrud","year":"2009","unstructured":"Sundrud MS, Koralov SB, Feuerer M, et al. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science. 2009;324(5932):1334\u20138.","journal-title":"Science"},{"issue":"1","key":"820_CR30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.chom.2008.12.006","volume":"5","author":"J Chow","year":"2009","unstructured":"Chow J, Mazmanian SK. Getting the bugs out of the immune system: do bacterial microbiota \u201cfix\u201d intestinal T cell responses? Cell Host Microbe. 2009;5(1):8\u201312.","journal-title":"Cell Host Microbe"},{"issue":"12","key":"820_CR31","doi-asserted-by":"crossref","first-page":"e51909","DOI":"10.1371\/journal.pone.0051909","volume":"7","author":"T Marinkovi\u0107","year":"2012","unstructured":"Marinkovi\u0107 T, Sysi-Aho M, Ore\u0161i\u010d M. Integrated model of metabolism and autoimmune response in \u03b2-cell death and progression to type 1 diabetes. PloS One. 2012;7(12):e51909. This is the first study presenting a mathematical model describing the progression of beta-cell death.","journal-title":"PloS One"},{"key":"820_CR32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.abb.2015.09.023","volume":"589","author":"K Suhre","year":"2016","unstructured":"Suhre K, Raffler J, Kastenm\u00fcller G. Biochemical insights from population studies with genetics and metabolomics. Arch Biochem Biophys. 2016;589:168\u201376.","journal-title":"Arch Biochem Biophys."}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-016-0820-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-016-0820-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-016-0820-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T04:14:09Z","timestamp":1718856849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-016-0820-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1007\/s11892-016-0820-9","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]},"article-number":"127"}}